Molecular Partners Ag (MOLN) Total Current Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Total Current Liabilities for 7 consecutive years, with $12.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 20.24% year-over-year to $12.4 million in Q2 2026; TTM through Jun 2026 was $12.4 million, a 20.24% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, up 8.49% from the prior year.
• Total Current Liabilities was $12.4 million for Q2 2026 at Molecular Partners Ag, up from $11.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $33.0 million in Q1 2022 and troughed at $10.0 million in Q1 2025.
• A 5-year average of $16.1 million and a median of $15.1 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities slumped 64.77% in 2022 and advanced 24.01% in 2025, its largest moves.
• Over 5 years, Total Current Liabilities stood at $17.9 million in 2022, then decreased by 9.24% to $16.3 million in 2023, then slipped by 24.25% to $12.3 million in 2024, then rose by 12.06% to $13.8 million in 2025, then decreased by 9.94% to $12.4 million in 2026.
• The last three Total Current Liabilities figures came in at $12.4 million (Q2 2026), $11.2 million (Q1 2026), and $13.8 million (Q4 2025), per Business Quant data.